Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Breast cancer is the most common malignancy of the female population the incidence is increasing mainly statistically
between 50s and 60s, 60s and 70s. Recently, however, we meet more often with the occurrence of breast cancer in women in
30s and significantly between 20 and 40 year. For women this age range is not exist preventive or screening mammography, in
Slovakia only sonography and only clinical self- examination by touch. The period from 1.5.2005 and 30.6.2016 we performed
more than 70000 mammography examinations and more than 185000 ultrasound examinations. The youngest patient was
6 months, the oldest 94 years. Patients were sent for examination by attending gynecologist, general practitioner. Preventive
examinations completed asymptomatic women without clinical symptoms. Young women and girls were examined by
ultrasound with 18 MHz linear proge, with CFM and elastography. Next if necessary, we performed mammography, MRmammography
a CCB too. During the monitored period we diagnosed 398 new cases of the breast cancer, all cases are verified
by histopathology. The age distribution of patients with newly diagnosed cancer we transparently stored in tables and graphs.
We focused on women in the age group to 39 and 49 year old. In category women between 18s and 39s we diagnosed 32 new
cases of breast cancer, between 40s and 49s 64 cases. Summary are 86 of new cases of the breast cancer in women between 18
and 49 years. We analyzed the different findings, especially with respect to possibility of diagnostic self-examination, combined
with ultrasound, MR mammography, mammography and core cut biopsy under ultrasound control. The number of the young
women with new diagnosed breast cancer slowly increased. Our aim is the early diagnostics, without vascular cancer vascular
invasivity, without the lymphadenopathy. We retrospectively focused on genetic anamnesis factor, short time of the diagnosis
and therapy.
Biography
Jana Slobodnikova has done her MD from Prague Charles University. She has completed CSc/PhD from Institus of experimental Oncology Slovac Scientic Academy. She also worked as an Ass. Prof. Trnaviensis University. She has published more than 90 scientific papers, from then 25 papers in reputed journals and has been serving as an Editorial Board Member of repute. She has published 3 monographs. She is President of the section of breast imaging of Slovak Radiologic Society and Vice President of the Slovak Society of Ultrasound in Medicine.